Should We Be Using Time in Therapeutic Range as a Performance Measure for Hypertension Control?
Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.

A Patient With Metabolic Alkalosis: Multidisciplinary Dialogue: Clinical Rounds and Case Reviews, Ep. 4
Dr. Anil Harrison speaks with Paul Shiu, DO, about a patient with metabolic alkalosis, including the criteria, the most common causes, and the phases of metabolic alkalosis. 

How Times Have Changed: Diabetes Management
Kim A. Carmichael, MD, reflects on a 1990 article from Consultant’s archives about diabetes management, including major available insulins, the evolution of blood glucose meters, insulin pump technology, and the cost of insulin.

A Peculiar Retinal Scan in a Patient With Diabetes
A 70-year-old man with a medical history significant for well-controlled type 2 diabetes, hypertension, hyperlipidemia, and obesity presented to our primary care clinic for a diabetic retinopathy screen with the clinic’s new retinal scanner.

Treating Patients With Mild Hypertension During Pregnancy Improves Outcomes: The Chronic Hypertension and Pregnancy (CHAP) Trial
Michael J. Bloch, MD, writes about the risks and benefits of treating patients with mild to moderate hypertension during pregnancy and whether targeting blood pressure of less than 140/90 mmHg reduces the incidence of adverse pregnancy outcomes without compromising fetal outcomes.

The Relationship Between Waist Circumference, Liver Disease
Naim Alkhouri, MD, speaks about the relationship between waist circumference and NAFLD/ NASH, including the risk for NAFLD and fibrosis in people with HIV compared with the general population, the relationship between visceral fat and the liver, and why clinicians should use waist circumference to identify their patients most at risk for NAFLD and metabolic disease.